Table 5.
Evaluation of the quality of evidence using the GRADE guidelines.
| Anticipated effect | Certainty assessment | ||||||
|---|---|---|---|---|---|---|---|
| Pharmacotherapy | Risk of bias | Inconsistency | Indirectness | Imprecision | Publication bias | Sample size (number of studies) | Certainty of evidence (GRADE) |
| Antiviral (valacyclovir) | Serious risk of bias | Some inconsistency exists | Some indirectness exists | Some imprecision exists | Undetected | 256 (3) | Low |
| Antibiotics (ceftriaxone, doxycycline, amoxicillin, other) | Serious risk of bias | Some inconsistency exists | Some indirectness exists | Some imprecision exists | Undetected | 521 (5) | Low |
| Non-opioid analgesic (flupirtine maleate) | Serious risk of bias | Some inconsistency exists | Some indirectness exists | Some imprecision exists | Undetected | 28 (1) | Very low |